pharmaphorum

APRIL 8, 2021

COVID-19 has been a trial-by-fire showing just how quickly drugs and vaccines can be developed under the right circumstances – but there is much to do to ensure this progress is not lost, said speakers at WIRED Health 2021, including the CEOs of BioNTech and BenevolentAI. . BioNTech seeks “new kind of pharma company”.

Drug Development 93

Drug Development Vaccines Documentation Communication 93

Pharma Mirror

APRIL 24, 2022

Sweden-based NorthX Biologics (“NorthX”), which focuses on process development and large-scale production of advanced biological drugs, has signed a collaboration agreement with Abera Bioscience (“Abera”) for upscaling and GMP manufacturing of its vaccine candidate against pneumococcus, Ab-01.12.

Vaccines 52

Vaccines Drug Development 52

pharmaphorum

DECEMBER 23, 2022

There’s been huge progress in treatments for blood cancer in recent years – but drawbacks of expensive CAR-T cell and injected antibody therapies have led drug developers to look at novel oral therapies as patient-friendly alternatives.

Drug Development 52

Drug Development Immunization Immunity Hospitals 52

pharmaphorum

JANUARY 15, 2021

Now, speaking to him as the first vaccines are deployed in the UK, he highlights the importance of GSK’s employees and culture to the future of the company post-COVID. George Underwood is pharmaphorum’s Deep Dive magazine editor, leading the content for the bi-monthly magazine. About the author.

Vaccines 105

Vaccines Drug Development 105

pharmaphorum

SEPTEMBER 1, 2020

George Merck on the cover of Time magazine. Thalidomide and the development of drug safety regulation and monitoring. Fordian methods enabled more rational methods of mass production, and increasing understanding of biology and chemistry enabled drug candidates to be chosen systematically rather than discovered serendipitously.

Diabetes 145

Diabetes Immunity Immunization Vaccines 145